Prazosin: Effective Management of Hypertension and PTSD Nightmares

Prazosin

Price from 74.82 $

Show more

Product dosage: 5mg
Package (num)	Per pill	Price	Buy
30	$2.49	$74.82 (0%)	🛒 Add to cart
60	$2.09	$149.64 $125.56 (16%)	🛒 Add to cart
90	$1.96	$224.46 $176.30 (21%)	🛒 Add to cart
120	$1.89	$299.28 $227.04 (24%)	🛒 Add to cart
180	$1.82	$448.92 $327.66 (27%)	🛒 Add to cart
270	$1.78	$673.38 $479.88 (29%)	🛒 Add to cart
360	$1.76 Best per pill	$897.84 $633.82 (29%)	🛒 Add to cart
Synonyms Prazosinum Minizide Prazopress Hypovase

Prazosin hydrochloride is a selective alpha-1 adrenergic receptor antagonist, a quinazoline derivative indicated primarily for the treatment of hypertension. Its mechanism of action involves blocking postsynaptic alpha-1 adrenoreceptors, leading to peripheral vasodilation and a subsequent reduction in blood pressure. More recently, its utility has been significantly expanded into the psychiatric domain, where it is recognized as a first-line pharmacologic intervention for trauma-related nightmares and sleep disturbances in Post-Traumatic Stress Disorder (PTSD). This dual therapeutic profile makes it a versatile agent in both cardiovascular and neuropsychiatric medicine, offering a targeted approach to symptom management with a well-established safety record.

Features

• Selective alpha-1 adrenergic receptor antagonist.
• Available in 1 mg, 2 mg, and 5 mg immediate-release oral capsules.
• Bioavailability is approximately 60% and is not significantly affected by food.
• Peak plasma concentrations are reached within 1-3 hours post-administration.
• Primarily metabolized in the liver via demethylation and conjugation; not a significant substrate, inhibitor, or inducer of the CYP450 enzyme system.
• Elimination half-life is approximately 2-3 hours; duration of antihypertensive effect can persist for 7-10 hours.
• Excreted mainly via the feces (via bile) and, to a lesser extent, the urine.

Benefits

• Provides smooth, controlled reduction of elevated blood pressure, reducing long-term cardiovascular risk.
• Effectively diminishes the frequency and intensity of trauma-related nightmares, improving sleep architecture and quality.
• Does not typically cause significant alterations in heart rate (minimal reflex tachycardia) due to its selective mechanism.
• Offers a non-habit-forming alternative for sleep disturbances compared to benzodiazepines or other sedative-hypnotics.
• Can be used as part of a combination antihypertensive regimen, often working synergistically with other drug classes like diuretics or beta-blockers.
• Improves overall daytime functioning and PTSD symptom burden in patients by facilitating restorative sleep.

Common use

Prazosin is most commonly prescribed for the management of hypertension, either as monotherapy or, more frequently, as part of a combination regimen. Its second, and equally prominent, indication is for the treatment of nightmares and sleep disruption associated with PTSD. Off-label, it is sometimes used in the management of symptoms related to benign prostatic hyperplasia (BPH), due to its relaxing effect on smooth muscle in the bladder neck and prostate, and for the treatment of Raynaud’s phenomenon. Its use in PTSD is supported by extensive clinical evidence and is considered a standard of care in many treatment guidelines.

Dosage and direction

Dosage must be individualized based on the patient’s therapeutic response and tolerance.

For Hypertension:

• Initial Dose: 1 mg two or three times daily.
• Maintenance Dose: May be increased gradually to a total daily dose of 20 mg given in divided doses. The therapeutic dosage range is commonly 6 mg to 15 mg daily administered in divided doses. Doses exceeding 20 mg daily usually do not increase efficacy.
• Administration: Can be taken with or without food. The same time(s) each day should be maintained for consistent control.

For PTSD-Associated Nightmares:

• Initial Dose: 1 mg at bedtime is standard to assess tolerance.
• Titration: The dose is typically titrated upward in 1 mg increments every 3-7 days based on therapeutic response and side effects.
• Target Dose: Most patients respond to a dose between 3 mg and 15 mg at bedtime. Some individuals, particularly those with severe symptoms, may require divided dosing (e.g., a dose at bedtime and a smaller dose during the day for intrusive symptoms).

The “first-dose effect” (acute hypotension) is a known phenomenon; therefore, the initial dose is always administered at bedtime. Patients should be advised not to drive or operate machinery for 12-24 hours after the first dose or any significant dose increase.

Precautions

• Orthostatic Hypotension: Syncope and dizziness, particularly with the first dose or after a rapid dose increase, can occur. Patients should be cautioned to rise slowly from a sitting or lying position.
• Intraoperative Floppy Iris Syndrome (IFIS): This alpha-1 blocker class effect has been observed during cataract surgery. Surgeons should be informed of prazosin use prior to any cataract procedure.
• Impaired Hepatic Function: Use with caution in patients with liver disease, as metabolism may be reduced, leading to increased drug levels.
• Renal Impairment: While dosage adjustment is not typically necessary, caution is advised. Drug accumulation can occur in severe renal impairment.
• Pregnancy & Lactation: Category C. Use only if the potential benefit justifies the potential risk to the fetus. It is not known whether prazosin is excreted in human milk; caution is advised if administering to a nursing woman.

Contraindications

Prazosin is contraindicated in patients with a known hypersensitivity to prazosin or any other quinazolines (e.g., doxazosin, terazosin). Its use is also contraindicated in conditions where vasodilation and a drop in blood pressure could be dangerous, such as in patients with hypotension or cardiogenic shock.

Possible side effect

Common side effects are generally related to its pharmacological action (vasodilation) and are often dose-dependent and transient.

• Very Common (>10%): Dizziness, drowsiness, headache.
• Common (1-10%): Lack of energy, palpitations, nausea, weakness.
• Uncommon (0.1-1%): Syncope (especially first-dose), blurred vision, dry mouth, nasal congestion, rash, urinary frequency.
• Rare (<0.1%): Priapism (prolonged and painful erection), which is a medical emergency requiring immediate treatment.

Drug interaction

Prazosin can have additive effects when combined with other agents that lower blood pressure, potentially increasing the risk of hypotension, dizziness, and syncope.

• Other Antihypertensives: Diuretics, beta-blockers, calcium channel blockers, ACE inhibitors, angiotensin II receptor blockers.
• Phosphodiesterase-5 Inhibitors (e.g., sildenafil, tadalafil): Concomitant use can cause severe hypotension.
• Central Nervous System Depressants: Alcohol, benzodiazepines, opioids, and other sedatives can potentiate drowsiness and dizziness.
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): May attenuate the antihypertensive effect of prazosin.

Missed dose

If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Do not double the dose to make up for a missed one.

Overdose

Symptoms of overdose are primarily an extension of its pharmacological effects and can lead to profound hypotension, resulting in shock, syncope, and depressed cardiac function. Circulatory support is of primary importance. The patient should be placed in a supine position with legs elevated. If necessary, vasopressor agents (e.g., norepinephrine) may be used to support blood pressure. Gastric lavage or activated charcoal may be considered if ingestion was recent. As prazosin is highly protein-bound, dialysis is not likely to be of benefit.

Storage

Store at room temperature (20°C to 25°C or 68°F to 77°F) in a tight, light-resistant container. Keep away from excess moisture and heat. Keep all medications out of the reach of children and pets.

Disclaimer

This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.

Reviews

Clinical studies and meta-analyses consistently demonstrate prazosin’s efficacy. For hypertension, it is a well-tolerated option within its drug class. Its most significant impact in recent literature is within psychiatry. A substantial body of evidence, including numerous randomized controlled trials, supports its use for PTSD nightmares, showing statistically significant and clinically meaningful reductions in nightmare frequency, improved sleep quality, and decreased overall PTSD severity. Many experts and treatment guidelines now consider it a cornerstone of pharmacotherapy for this specific symptom cluster. Patient-reported outcomes often highlight a transformative restoration of sleep, which is frequently cited as a critical factor in their overall recovery journey.